Nuveen Asset Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Nuveen Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $351,829 - $559,384	-253,115 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $10,288 - $27,705	8,101 Added 3.31%	253,115 $2.34 Million
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $781,708 - $4.89 Million	-521,139 Reduced 68.02%	245,014 $2.27 Million
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $2.46 Million - $4.31 Million	513,687 Added 203.47%	766,153 $6.43 Million
Q1 2020 May 14, 2020	BUY	$3.44 - $7.21 $166,293 - $348,538	48,341 Added 23.68%	252,466 $1.32 Million
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $56,881 - $82,694	-11,680 Reduced 5.41%	204,125 $994,000
Q2 2019 Aug 15, 2019	BUY	$6.6 - $7.8 $1.42 Million - $1.68 Million	215,805 New	215,805 $1.5 Million

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.